Articles dans des revues avec comité de lecture (50)
  1. 11. Vertongen, P., Langlet, C., Langer, I., Gaspard, N., & Robberecht, P. (2004). Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors. Peptides, 25(11), 1943-1949. doi:10.1016/j.peptides.2004.06.001
  2. 12. Langer, I., Grégoire, F., Nachtergael, I., De Neef, P., Vertongen, P., & Robberecht, P. (2004). Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency. Peptides, 25(2), 275-278. doi:10.1016/j.peptides.2003.12.013
  3. 13. Fuks, B., Gillard, M., Michel, P., Lynch, B., Vertongen, P., Leprince, P., Klitgaard, H., & Chatelain, P. (2003). Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. European journal of pharmacology, 478(1), 11-19. doi:10.1016/j.ejphar.2003.08.033
  4. 14. Gillard, M., Fuks, B., Michel, P., Vertongen, P., Massingham, R., & Chatelain, P. (2003). Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain. European journal of pharmacology, 478(1), 1-9. doi:10.1016/j.ejphar.2003.08.032
  5. 15. Nachtergael, I., Vertongen, P., Langer, I., Perret, J., Robberecht, P., & Waelbroeck, M. (2003). Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor. Biochemical journal, 370(Pt 3), 1003-1009. doi:10.1042/BJ20020811
  6. 16. Langer, I., Vertongen, P., Perret, J., Waelbroeck, M., & Robberecht, P. (2003). Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists. Neuropharmacology, 44(1), 125-131.
  7. 17. Langer, I., Vertongen, P., Perret, J., Cnudde, J., Grégoire, F., De Neef, P., Robberecht, P., & Waelbroeck, M. (2002). VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cells. Cellular signalling, 14(8), 689-694.
  8. 18. Perret, J., Vertongen, P., Solano Haro, R., Langer, I., Cnudde, J. G., Robberecht, P., & Waelbroeck, M. (2002). Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation. British Journal of Pharmacology, 136(7), 1042-1048. doi:10.1038/sj.bjp.0704802
  9. 19. Langer, I., Vertongen, P., Perret, J., Waelbroeck, M., & Robberecht, P. (2002). A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector. Biochemical Society transactions, 30(4), 447-450. doi:10.1042/
  10. 20. Langer, I., Vertongen, P., Perret, J., Waelbroeck, M., & Robberecht, P. (2002). A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector. Molecular endocrinology, 16(5), 1089-1096.
  11. 21. Perret, J., Van Craenenbroeck, M., Langer, I., Vertongen, P., Grégoire, F., Robberecht, P., & Waelbroeck, M. (2002). Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue. Biochemical journal, 362(Pt 2), 389-394.
  12. 22. Langer, I., Perret, J., Vertongen, P., Waelbroeck, M., & Robberecht, P. (2001). Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16. Cell calcium, 30(4), 229-234. doi:10.1054/ceca.2001.0230
    13. << Précédent 1 2 3 4 5 Suivant >>